Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study
- PMID: 17768135
- DOI: 10.3324/haematol.11352
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study
Abstract
We evaluated the prevalences of metabolic syndrome (MS) and hyperhomocysteinemia in patients with unprovoked deep vein thrombosis (DVT) and in controls. MS and hyperhomocysteinemia were significantly more prevalent in DVT patients than in controls. However, only the presence of MS was independently associated with DVT, and the coexistence of both risk factors did not increase the magnitude of the association.
Similar articles
-
The metabolic syndrome and the risk of venous thrombosis: a case-control study.J Thromb Haemost. 2006 Sep;4(9):1914-8. doi: 10.1111/j.1538-7836.2006.02132.x. Epub 2006 Jul 17. J Thromb Haemost. 2006. PMID: 16848878
-
Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors.Am J Epidemiol. 2018 Jul 1;187(7):1392-1400. doi: 10.1093/aje/kwy004. Am J Epidemiol. 2018. PMID: 29370361
-
[Hyperhomocysteinemia, risk factor in deep venous thrombosis: a case-control study].Rev Med Chir Soc Med Nat Iasi. 2009 Jan-Mar;113(1):68-72. Rev Med Chir Soc Med Nat Iasi. 2009. PMID: 21495299 Romanian.
-
Hyperhomocysteinemia and venous thrombosis.Semin Thromb Hemost. 1998;24(4):387-91. doi: 10.1055/s-2007-996027. Semin Thromb Hemost. 1998. PMID: 9763356 Review.
-
[Hyperhomocysteinemia as a risk factor for venous thrombosis].Ned Tijdschr Geneeskd. 1999 Mar 13;143(11):552-6. Ned Tijdschr Geneeskd. 1999. PMID: 10321272 Review. Dutch.
Cited by
-
Clinical Features and Developing Risks of Saphenous Vein Thrombophlebitis.Ann Vasc Dis. 2016;9(2):85-90. doi: 10.3400/avd.oa.16-00017. Epub 2016 May 4. Ann Vasc Dis. 2016. PMID: 27375800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical